Outcome of liver transplantation using donors 60 to 79 years of age

Transplant Proc. 1995 Feb;27(1):1184-5.

Authors

I R Marino¹, H R Doyle, C Doria, L Aldrighetti, T Gayowski, C Scotti-Foglieni, H Furukawa, J J Fung, A G Tzakis, T E Starzl

Affiliation

¹ Division of Transplantation, Pittsburgh Transplantation Institute, University of Pittsburgh, Pennsylvania.

PMID: 7748258
PMCID: PMC2972707

No abstract available

Publication types

Clinical Trial
Comparative Study
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Actuarial Analysis
Adult
Age Factors
Aged
Alanine Transaminase / blood
Aspartate Aminotransferases / blood
Cardiovascular Diseases / epidemiology
Graft Rejection / epidemiology
Graft Survival*
Hepatitis / epidemiology
Humans
Liver Transplantation / mortality
Liver Transplantation / physiology*
Middle Aged
Postoperative Complications / epidemiology
Survival Rate
Tissue Donors*
Treatment Failure

Substances

Aspartate Aminotransferases
Alanine Transaminase

Grants and funding